---
title: "Astrotech Reports Third Quarter of Fiscal Year 2026 Financial Results | ASTC Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286258402.md"
description: "Astrotech Reports Third Quarter of Fiscal Year 2026 Financial Results | ASTC Stock News"
datetime: "2026-05-13T04:10:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286258402.md)
  - [en](https://longbridge.com/en/news/286258402.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286258402.md)
---

# Astrotech Reports Third Quarter of Fiscal Year 2026 Financial Results | ASTC Stock News

Astrotech Reports Third Quarter of Fiscal Year 2026 Financial Results | ASTC Stock News

### Related Stocks

- [ASTC.US](https://longbridge.com/en/quote/ASTC.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)

## Related News & Research

- [08:00 ETAvance Clinical Receives Frost & Sullivan's 2026 Global Company of the Year Recognition for Excellence in Biotech CRO Leadership](https://longbridge.com/en/news/286094661.md)
- [Full Transcript: Cellectar Biosciences Q1 2026 Earnings Call](https://longbridge.com/en/news/286422585.md)
- [Precigen Q1 revenue beats estimates on PAPZIMEOS launch](https://longbridge.com/en/news/286311056.md)
- [Genprex data shows gene therapy reverses hyperglycemia in T2D mice at ASGCT](https://longbridge.com/en/news/286414681.md)
- [Regenxbio's muscle disorder therapy meets main goal in late-stage study](https://longbridge.com/en/news/286406339.md)